Forman AD - Search Results

1

Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer.

Holmes FA, Walters RS, Theriault RL, Forman AD, Newton LK, Raber MN, Buzdar AU, Frye DK, Hortobagyi GN. Holmes FA, et al. Among authors: forman ad. J Natl Cancer Inst. 1991 Dec 18;83(24):1797-805. doi: 10.1093/jnci/83.24.1797-a. J Natl Cancer Inst. 1991. PMID: 1683908 Clinical Trial.

2

Phase II trial and pharmacokinetic evaluation of cytosine arabinoside for leptomeningeal metastases from breast cancer.

Esteva FJ, Soh LT, Holmes FA, Plunkett W, Meyers CA, Forman AD, Hortobagyi GN. Esteva FJ, et al. Among authors: forman ad. Cancer Chemother Pharmacol. 2000;46(5):382-6. doi: 10.1007/s002800000173. Cancer Chemother Pharmacol. 2000. PMID: 11127942

3

Phase I/II clinical trial of didemnin B in non-small-cell lung cancer: neuromuscular toxicity is dose-limiting.

Shin DM, Holoye PY, Murphy WK, Forman A, Papasozomenos SC, Hong WK, Raber M. Shin DM, et al. Cancer Chemother Pharmacol. 1991;29(2):145-9. doi: 10.1007/BF00687325. Cancer Chemother Pharmacol. 1991. PMID: 1662119 Clinical Trial.

4

Phase II clinical trial of didemnin B in previously treated small cell lung cancer.

Shin DM, Holoye PY, Forman A, Winn R, Perez-Soler R, Dakhil S, Rosenthal J, Raber MN, Hong WK. Shin DM, et al. Invest New Drugs. 1994;12(3):243-9. doi: 10.1007/BF00873966. Invest New Drugs. 1994. PMID: 7896544 Review.

5

High-dose ifosfamide-induced exacerbation of peripheral neuropathy.

Patel SR, Forman AD, Benjamin RS. Patel SR, et al. Among authors: forman ad. J Natl Cancer Inst. 1994 Feb 16;86(4):305-6. doi: 10.1093/jnci/86.4.305. J Natl Cancer Inst. 1994. PMID: 8158686 No abstract available.

6

Phase II study of docetaxel in patients with epithelial ovarian carcinoma refractory to platinum.

Kavanagh JJ, Kudelka AP, de Leon CG, Tresukosol D, Hord M, Finnegan MB, Kim EE, Varma D, Forman A, Cohen P, Edwards CL, Freedman RS, Verschraegen CF. Kavanagh JJ, et al. Clin Cancer Res. 1996 May;2(5):837-42. Clin Cancer Res. 1996. PMID: 9816238 Clinical Trial.

7

Phase II study of i.v. CI-980 in patients with advanced platinum refractory epithelial ovarian carcinoma.

Kudelka AP, Hasenburg A, Verschraegen CF, Edwards CL, Meyers CA, Varma D, Freedman RS, Forman A, Conrad CA, Grove W, Grothey A, Kavanagh JJ. Kudelka AP, et al. Anticancer Drugs. 1998 Jun;9(5):405-9. doi: 10.1097/00001813-199806000-00006. Anticancer Drugs. 1998. PMID: 9660537 Clinical Trial.

8

Carpal tunnel syndrome associated with interleukin-2 therapy.

Puduvalli VK, Sella A, Austin SG, Forman AD. Puduvalli VK, et al. Among authors: forman ad. Cancer. 1996 Mar 15;77(6):1189-92. doi: 10.1002/(sici)1097-0142(19960315)77:6<1189::aid-cncr27>3.0.co;2-x. Cancer. 1996. PMID: 8635142

9

Peripheral neuropathy in cancer patients: incidence, features, and pathophysiology.

Forman A. Forman A. Oncology (Williston Park). 1990 Jan;4(1):57-62 concl. Oncology (Williston Park). 1990. PMID: 2168199 Review.

10

A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies.

Groves MD, Glantz MJ, Chamberlain MC, Baumgartner KE, Conrad CA, Hsu S, Wefel JS, Gilbert MR, Ictech S, Hunter KU, Forman AD, Puduvalli VK, Colman H, Hess KR, Yung WK. Groves MD, et al. Among authors: forman ad. Neuro Oncol. 2008 Apr;10(2):208-15. doi: 10.1215/15228517-2007-059. Epub 2008 Mar 3. Neuro Oncol. 2008. PMID: 18316473 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters